AsiaMedic Limited (505.SI)
- Previous Close
0.0100 - Open
0.0110 - Bid 0.0110 x --
- Ask 0.0120 x --
- Day's Range
0.0110 - 0.0120 - 52 Week Range
0.0090 - 0.0130 - Volume
600,900 - Avg. Volume
503,495 - Market Cap (intraday)
12.7M - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Mar 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 29, 2010
- 1y Target Est
--
AsiaMedic Limited, an investment holding company, provides healthcare services in Singapore. It offers diagnostic imaging, radiology, health screening, and medical wellness services, as well as medical aesthetic services and related products. The company also provides medical imaging services, such as MRI Scan, CT scan, PET CT, Mammogram, BMD, Zed Doctor, magnetic resonance imaging MRI, computed tomography CT, bone densitometry DEXA, ultrasound, and bone mineral densitometry; and radiological examinations includes cardiovascular, musculoskeletal, ear nose & throat ENT, breast, body and neuroradiology. In addition, the company provides positron emission tomography/computed tomography PET/CT scans for cardiac and cancer imaging. Additionally, it operates aesthetic clinics; and medical arrangement, travel medical concierge, diagnostic scan, wellness, medical evacuation, and visa services. The company also sells pharmaceutical and aesthetic products. The company was incorporated in 1974 and is based in Singapore.
www.asiamedic.com.sg--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 505.SI
View MorePerformance Overview: 505.SI
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 505.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 505.SI
View MoreValuation Measures
Market Cap
11.55M
Enterprise Value
21.22M
Trailing P/E
11.11
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.40
Price/Book (mrq)
0.81
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
5.74
Financial Highlights
Profitability and Income Statement
Profit Margin
3.47%
Return on Assets (ttm)
1.07%
Return on Equity (ttm)
4.28%
Revenue (ttm)
29.09M
Net Income Avi to Common (ttm)
1.01M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.99M
Total Debt/Equity (mrq)
125.00%
Levered Free Cash Flow (ttm)
2.53M